title: The placenta as a site of cytomegalovirus infection in guinea pigs.
abstract: The development of cytomegalovirus (CMV) infection in the placenta was studied in Hartley guinea pigs inoculated at midgestation, and its role in determining the outcome of fetal CMV infection was assessed. A hematogenous spread of CMV from the mother to the placenta occurred early during the course of the infection. However, the virus remained present in placental tissues long after CMV had been cleared from maternal blood (i.e., 3 and 4 weeks postinoculation). At that time, the virus was able to replicate in placental tissues in the presence of specific maternal antibodies. Viral nucleocapsids were seen within nuclei of trophoblastic cells, and virions were present surrounding infected cells. In addition, typical CMV-induced histopathological lesions bearing CMV antigens were consistently localized at the transitional zone between the capillarized labyrinth and the noncapillarized interlobium. Whenever CMV infection of the fetus occurred, virus was isolated from the associated placenta. Among placental-fetal units with CMV-infected placentas, only 27% of the fetuses were found to be infected. In addition, there was a delay in the establishment of the infection in the fetus in relation to the placenta, although frequencies of virus isolation in placental and fetal tissues peaked at 3 weeks after CMV inoculation. These results suggest that during primary CMV infection of pregnant guinea pigs, the placenta not only serves as a reservoir for CMV but also acts to limit transmission of the virus to the fetus.
authors.forename: B P
authors.initials: BP
authors.lastname: Griffith
authors.forename: S R
authors.initials: SR
authors.lastname: McCormick
authors.forename: C K
authors.initials: CK
authors.lastname: Fong
authors.forename: J T
authors.initials: JT
authors.lastname: Lavallee
authors.forename: H L
authors.initials: HL
authors.lastname: Lucia
authors.forename: E
authors.initials: E
authors.lastname: Goff
mesh_terms: D000818:Animals; D003587:Cytomegalovirus / Q000254:growth & development* / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000382:microbiology* / Q000635:transmission; D005260:Female; D005315:Fetal Diseases / Q000382:microbiology; D006168:Guinea Pigs; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000382:microbiology* / Q000473:pathology; D010922:Placenta Diseases / Q000382:microbiology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D013997:Time Factors; D014327:Trophoblasts / Q000382:microbiology; D014766:Viremia